Accretion/Dilution Question

I got asked this question and was wondering what's the correct answer?

  1. Company A trades at $20/share, 100M shares outstanding, $100M in earnings. Company B trades at $10 shares, 50M shares, $100M earnings. Company A acquires Company B using all-stock. What is the purchase price? 
  1. using same numbers as above, given that post-tax synergies are $175M and tax rate is 35%, what is the seller and buyer's EPS and what is the proforma EPS? Is this deal accretive? How accretive is this deal?
4 Comments
 
Most Helpful

I'll start with some unsolicited commentary: this is a stupid set of questions, where someone was trying to feel smart and/or pressure test you. Here's my shot. 

1. What you know from the facts is that A has a market cap of $2,000mm and B has a market cap of $500mm. Assuming (i) no debt and (ii) no control premium [again, dumb question], the equity purchase price would be $500mm. If you were trying to win bonus points, one way to answer this would be to answer the more interesting question: "how much could company A pay for company B and still be accretive in an all-stock deal", which, given they have the same earnings, is $1,999mm, or anything less than $2,000mm.

2. Assuming the equity acquisition price is $500mm, A has to issue 25mm shares [again, simplifying assumption]. Earnings for the pro-forma business are $375mm (synergies are already quoted on a post-tax basis). $375mm divided by 125mm shares = $3 EPS, which is higher than $1 EPS of standalone A, so therefore this deal is accretive.       

 

Based on the most helpful WSO content, let's break down the question into parts to understand and solve it step by step.

Part 1: Purchase Price Calculation

To calculate the purchase price for Company B by Company A using an all-stock deal, we first need to determine the value of Company B's shares.

  • Company A's share price: $20
  • Company B's share price: $10
  • Company B's shares outstanding: 50M

The purchase price would be the share price of Company B multiplied by its shares outstanding, which is $10 * 50M = $500M.

Part 2: Calculating EPS and Assessing Accretion/Dilution

Given: - Post-tax synergies: $175M - Tax rate: 35%

First, let's calculate the after-tax synergies: - After-tax synergies = $175M * (1 - 0.35) = $113.75M

EPS Calculation:

  • Company A's earnings: $100M
  • Company A's shares outstanding: 100M
  • Company B's earnings: $100M
  • Combined earnings: $100M (A) + $100M (B) + $113.75M (synergies) = $313.75M

Since it's an all-stock deal, the number of shares issued by Company A to acquire Company B needs to be calculated. The purchase price is $500M, and Company A's share price is $20, so Company A would issue 25M shares ($500M / $20) to Company B's shareholders.

  • Total shares outstanding after the merger: 100M (A) + 25M (newly issued for B) = 125M

Now, we can calculate the EPS for the combined entity: - Proforma EPS: $313.75M / 125M shares = $2.51

Pre-merger EPS for comparison:

  • Company A's EPS: $100M / 100M shares = $1.00
  • Company B's EPS: $100M / 50M shares = $2.00

Accretion/Dilution Analysis:

  • Company A's EPS increases from $1.00 to $2.51, indicating the deal is accretive for Company A shareholders.
  • The deal's accretiveness can be quantified by the increase in EPS, which is $1.51 per share.

This simplified analysis, based on the highest ranked content on WSO, shows that the deal is accretive to Company A's shareholders, significantly increasing the EPS from $1.00 to $2.51. This calculation assumes all else being equal and focuses on the financial impact of the merger, specifically through EPS and synergies.

Sources: Common Accretion-Dilution Technical Question, Accretion / Dilution Technical Question, Accretion Follow-Up - Technical Question

I'm an AI bot trained on the most helpful WSO content across 17+ years.
 

Dolore doloribus est officiis corrupti. Voluptas consequatur et qui eum est dolores reprehenderit. Dolorem voluptas possimus non sapiente et autem. Porro voluptatum nostrum beatae temporibus distinctio eum velit. Cumque voluptatem recusandae rerum quia ut.

Modi ad est quo itaque ducimus. Recusandae eum exercitationem eligendi sint.

I'm an AI bot trained on the most helpful WSO content across 17+ years.

Career Advancement Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.3%
  • Guggenheim Partners 01 97.7%
  • Morgan Stanley 07 97.1%

Overall Employee Satisfaction

July 2026 Investment Banking

  • Moelis & Company No 99.4%
  • Evercore No 98.8%
  • Morgan Stanley 01 98.3%
  • BMO Capital Markets 13 97.7%
  • Banco Santander 01 97.1%

Professional Growth Opportunities

July 2026 Investment Banking

  • Evercore 01 99.4%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.3%
  • Goldman Sachs 01 97.7%
  • JPMorgan 01 97.1%

Total Avg Compensation

July 2026 Investment Banking

  • Vice President (15) $434
  • Associates (46) $258
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (22) $179
  • Intern/Summer Associate (13) $156
  • 1st Year Analyst (80) $150
  • Intern/Summer Analyst (73) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
BankonBanking's picture
BankonBanking
99.0
3
kanon's picture
kanon
99.0
4
Secyh62's picture
Secyh62
99.0
5
Betsy Massar's picture
Betsy Massar
98.9
6
dosk17's picture
dosk17
98.9
7
CompBanker's picture
CompBanker
98.9
8
GameTheory's picture
GameTheory
98.9
9
DrApeman's picture
DrApeman
98.9
10
Linda Abraham's picture
Linda Abraham
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”